RT @RimmPathology: Key paper came out today from our NCCN group, reanalysis of NCCN lung data at breast cancer cut-points? Still poor conc…
RT @RimmPathology: Key paper came out today from our NCCN group, reanalysis of NCCN lung data at breast cancer cut-points? Still poor conc…
RT @RimmPathology: Key paper came out today from our NCCN group, reanalysis of NCCN lung data at breast cancer cut-points? Still poor conc…
RT @RimmPathology: Key paper came out today from our NCCN group, reanalysis of NCCN lung data at breast cancer cut-points? Still poor conc…
RT @RimmPathology: Key paper came out today from our NCCN group, reanalysis of NCCN lung data at breast cancer cut-points? Still poor conc…
RT @RimmPathology: Key paper came out today from our NCCN group, reanalysis of NCCN lung data at breast cancer cut-points? Still poor conc…
Key paper came out today from our NCCN group, reanalysis of NCCN lung data at breast cancer cut-points? Still poor concordance...https://t.co/q0sD9JUL7W
Can a clinical trial provide useful information if it is based on an unreliable assay? https://t.co/95zJ6nrKny